Search results
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks via Yahoo Finance· 2 days agoNovavax (NVAX) seeks FDA???s approval to update its COVID-19 vaccine for the 2024-2025 fall season...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 5 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...
Feeling Sick After Your COVID Vaccine? According to Scientists, It’s Actually a Good Sign
SciTechDaily· 7 hours agoA UCSF study suggests that side effects like headaches and chills from COVID-19 vaccines indicate a...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 6 days agoYounger children, adults 65 and older and...vaccine in the fall.” The FDA has requested that vaccine...
Gateway - Quartz
Quartz· 19 hours agoModerna said Tuesday that its updated COVID-19 vaccine demonstrated a stronger immune response ...
Moderna says next-gen COVID shot effective in study
BioPharma Dive via Yahoo Finance· 7 days agoTrial data suggest the shot — an important component of an upcoming combination inoculation — has proven at least as effective, and in some cases...
Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation COVID-...
The Kansas City Star· 7 days agomRNA-1283 met its primary vaccine efficacy endpoint in a Phase 3 trial, demonstrating non-inferior vaccine efficacy against COVID-< ...
Moderna Just Gave Investors Another Reason to Buy the Stock
The Motley Fool via AOL· 3 days agovaccine. This technology was unproven until 2020 (no mRNA-based vaccine had been approved or granted...
... 2b Clinical Study Evaluating the Company's Next-Generation COVID-19 Vaccine Candidate,...
NewMediaWire via Yahoo Finance· 2 days ago10,000-participant randomized Phase 2b study will evaluate and compare GeoVax's multi-antigen, ...
FDA asks COVID vaccine makers to target KP.2 strain, if feasible, for next shot
Reuters via Yahoo News· 5 days agoThe Food and Drug Administration's change in recommendation, in an update dated Thursday, comes even...
